Iceni Gold Ltd

ICL to Acquire Lavie Bio: Strategic Move to Advance AI-Driven Agricultural Biologicals

- ICL has signed a definitive agreement to acquire the majority of Evogene's subsidiary Lavie Bio, a leader in microbiome-based agricultural biological products, with the transaction expected to close in Q2 2025. - The acquisition includes Lavie Bio's core team, BDD technology platform, microbial bank, development programs, commercial products, and Evogene's MicroBoost AI for AG platform. - This strategic move follows over two years of collaboration between the companies and aims to accelerate the development of innovative bio-stimulant solutions for crops facing abiotic stresses.